These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications. Kopp SW; Bang HK Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219 [TBL] [Abstract][Full Text] [Related]
24. Educating patients about their medications: the potential and limitations of written drug information. Shrank WH; Avorn J Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751 [TBL] [Abstract][Full Text] [Related]
26. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling. Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508 [TBL] [Abstract][Full Text] [Related]
27. Prescription of hazardous drugs during pregnancy. Malm H; Martikainen J; Klaukka T; Neuvonen PJ Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977 [TBL] [Abstract][Full Text] [Related]
28. Requirements for FDA-approved patient information spelled out in final rule. Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523 [No Abstract] [Full Text] [Related]
29. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals. Hung JC; Ponto JA; Gadient KR; Frie JA; Aksamit CM; Enquist CL; Carrels KE J Am Pharm Assoc (2003); 2004; 44(1):30-5. PubMed ID: 14965150 [TBL] [Abstract][Full Text] [Related]
30. Drug safety labeling for doctors. Hecht A FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108 [TBL] [Abstract][Full Text] [Related]
31. Categorizing the safety of medications during pregnancy and lactation. Howland RH J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):17-20. PubMed ID: 19437927 [TBL] [Abstract][Full Text] [Related]
32. Similarities and differences between US and Japan as to pharmacogenomic biomarker information in drug labels. Otsubo Y; Asahina Y; Noguchi A; Sato Y; Ando Y; Uyama Y Drug Metab Pharmacokinet; 2012; 27(1):142-9. PubMed ID: 22201121 [TBL] [Abstract][Full Text] [Related]
33. [Patient-oriented package inserts for drugs. Historical overview and current status]. Van Haecht CH; Vander Stichele R; Bogaert M Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065 [TBL] [Abstract][Full Text] [Related]
34. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling. Willy ME; Li Z Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):201-6. PubMed ID: 15255086 [TBL] [Abstract][Full Text] [Related]
35. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. Roberts R; Rodriguez W; Murphy D; Crescenzi T JAMA; 2003 Aug; 290(7):905-11. PubMed ID: 12928467 [TBL] [Abstract][Full Text] [Related]
36. An exploratory study of drug abuse and dependence information in package inserts. Phipps LB; Balster RL; Slattum PW; Kirkwood CK J Addict Dis; 2007; 26(2):25-34. PubMed ID: 17594995 [TBL] [Abstract][Full Text] [Related]
37. Rx with a dose of info. Miller RW FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292 [TBL] [Abstract][Full Text] [Related]
38. [Drug package inserts and the adequacy of patient's drug information]. da Silva T; Dal-Pizzol F; Bello CM; Mengue SS; Schenkel EP Rev Saude Publica; 2000 Apr; 34(2):184-9. PubMed ID: 10881155 [TBL] [Abstract][Full Text] [Related]
39. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Addis A; Sharabi S; Bonati M Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706 [TBL] [Abstract][Full Text] [Related]
40. Medication use in pregnancy and the pregnancy and lactation labeling rule. Sahin L; Nallani SC; Tassinari MS Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]